CSHNX
Price
$12.51
Change
+$0.06 (+0.48%)
Updated
Jan 17 closing price
Net Assets
1.17B
IMLPX
Price
$11.05
Change
+$0.05 (+0.45%)
Updated
Jan 17 closing price
Net Assets
902.74M
Ad is loading...

CSHNX vs IMLPX

Header iconCSHNX vs IMLPX Comparison
Open Charts CSHNX vs IMLPXBanner chart's image
NYLI Cushing® MLP Premier Investor Class
Price$12.51
Change+$0.06 (+0.48%)
VolumeN/A
Net Assets1.17B
MainGate MLP I
Price$11.05
Change+$0.05 (+0.45%)
VolumeN/A
Net Assets902.74M
CSHNX vs IMLPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSHNX vs. IMLPX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSHNX is a Hold and IMLPX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CSHNX has more cash in the bank: 1.17B vs. IMLPX (903M). CSHNX pays higher dividends than IMLPX: CSHNX (7.86) vs IMLPX (4.53). CSHNX was incepted earlier than IMLPX: CSHNX (11 years) vs IMLPX (14 years). CSHNX is a more actively managed with annual turnover of: 20.00 vs. IMLPX (8.27). CSHNX has a lower initial minimum investment than IMLPX: CSHNX (2500) vs IMLPX (1000000). CSHNX annual gain was more profitable for investors over the last year : 57.33 vs. IMLPX (48.18). IMLPX return over 5 years is better than : 138.93 vs. CSHNX (85.63).
CSHNXIMLPXCSHNX / IMLPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years14 years-
Gain YTD9.5458.546112%
Front LoadN/AN/A-
Min. Initial Investment250010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.17B903M129%
Annual Yield % from dividends7.864.53173%
Returns for 1 year57.3348.18119%
Returns for 3 years104.90112.5593%
Returns for 5 years85.63138.9362%
Returns for 10 years34.4672.6747%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARWR19.560.54
+2.84%
Arrowhead Pharmaceuticals
AXR32.780.51
+1.58%
AMREP Corp
SNN25.290.24
+0.96%
Smith & Nephew plc
CTLP8.150.04
+0.49%
Cantaloupe
VRPX0.30-0.01
-2.06%
Virpax Pharmaceuticals